Callon Petroleum Company (NYSE:CPE) Analyst Evaluation

Callon Petroleum Company (NYSE:CPE) currently has mean rating of 1.80 while 15 analysts have commented the shares as ‘BUY’, 7 recommended as ‘OUTPERFORM’ and 3 commented as ‘HOLD’. The rating score is on a scale of 1-5 where 1 stands for strong buy and 5 stands for strong sell. The mean price target for the equity is at $19.46 while the highest price target suggested by the brokerage firms is $26.00 and low price target is $12.42. The mean price target is calculated keeping in view the consensus of 26 analysts.

The mean revenue estimate for the ongoing quarter ending Dec 16 is $72.04M by 18 analysts. The average forecast of sales for the year ending Dec 16 is $205.45M by 14 financial experts.

Callon Petroleum Company (NYSE:CPE) went down -1.04% during trading on 01/10/2017, with the company’s shares hitting the price near $15.26. The stock had a trading capacity of 4M shares. The firm has a SMA 50 (Simple Moving Average) of -0.56% and a SMA 200-(Simple Moving Average) of 17.02%. This appreciation has taken its market valuation to 3.08B. Shares registered one year high at $18.53 and the one year low of $4.21.

Earnings Summary

In Callon Petroleum Company (NYSE:CPE) latest quarter ended on 30 Sep 2016, company revealed earnings of $0.09 a share. The reported earnings topped the analyst’s consensus by $0.02 with the surprise factor around 28.60%. In the matter of earnings surprises, it can have a huge impact on a company’s stock price. Several studies suggest that positive earnings surprises not only lead to an immediate hike in a stock’s price, but also to a gradual increase over time.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) went down -1.08% during trading on 01/10/2017, closing at $37.50. The stock had a trading capacity of 1.31M shares. The firm has a SMA 50 (Simple Moving Average) of 2.35% and a SMA 200-(Simple Moving Average) of -24.38%. This appreciation has taken its current market value to3.20B and a price-to-earnings ratio to 657.89. Shares registered one year high at $65.06 and the one year low of $32.54.

Stock Analyst-Opinion Require Close Attention: Acadia Healthcare Company, Inc. (NASDAQ:ACHC) 

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares currently have a mean rating of 1.50 while 7 analysts have recommended the shares as ‘BUY’, 8 commented as ‘OUTPERFORM’ and 1 commented as ‘HOLD’. The rating score is on a scale of 1-5 where 1 stands for strong buy and 5 stands for sell. The mean price target for the company’s stock is $52.00 while the highest price target suggested by the analysts is $60.00 and low price target is $43.00. The mean price target is calculated keeping in view the consensus of 15 brokerage firms.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has a mean revenue estimate for the ongoing quarter ending Dec 16 of $708.99M, according to 14 analysts. The average forecast of sales for the year ending Dec 16 is $2.82B by 15 analysts.

Earnings Overview For Acadia Healthcare Company, Inc.

Company latest quarter ended on 30 Sep 2016. There were earnings of $0.58 per share. The reported earnings missed the analyst’s consensus by $-0.03 with the surprise factor of -4.90%.